Copper prices rose slightly on Wednesday, as the US dollar slipped against most of its peers, amid optimism following news about Covid-19 vaccines.
The American company Pfizer and the German firm BioNTech announced on Wednesday that the recent data from the final phase of the clinical trials on their Covid-19 vaccine showed it was 95% effective.
The vaccine was found to be effective in preventing the virus within 28 days after the first dose, and was consistent across age, especially the elderly.
Pfizer is preparing to apply for emergency authorization very soon in order to distribute the vaccine next December.
The dollar index fell against a basket of major currencies by 0.1% to 92.3 points as of 14:36 GMT, after hitting a high of 92.5 points and a low of 92.2 points.
Copper December futures rose 0.2% to $3.21 per pound as of 14:35 GMT, with a high of $3.25 and a low of $3.20.
Thanks for your feedback.
The major US stock indices were mixed at early trading on Wednesday, despite Pfizer's announcement of its Covid-19 vaccine.
MoreThe US crude continued to rise on Wednesday, gaining more than 2.5%, while heading for the second gain in 3 days after taking a pause yesterday, on strong odds for OPEC-Plus delaying the output increase scheduled early next year, which offset a sudden build in the US crude inventories according to preliminary data, and ahead of the Energy Information Administration's official report.
MoreEuropean stocks rose on Wednesday, and resumed gains after pausing yesterday on profit-taking, to rise today near a 9-month high, after the American company Pfizer said that its Covid-19 vaccine is 95% effective in preventing the virus according to the final phase of the clinical trials.
More